Open AccessUnmet Care Needs and Financial Hardship in Patients With Metastatic Non–Small-Cell Lung Cancer on Immunotherapy or Chemoimmunotherapy in Clinical Practice
Author(s) -
Laurie E. McLouth,
Chandylen L Nightingale,
Beverly Levine,
Jessica L. Burris,
Jean A. McDougall,
Thomas Lycan,
Jennifer Gabbard,
Jimmy Ruiz,
Michael Farris,
A. William Blackstock,
Stefan C. Grant,
W. Jeffrey Petty,
Kathryn E. Weaver
Publication year - 2021
Publication title -
jco oncology practice
Language(s) - English
Resource type - Journals
eISSN - 2688-1535
pISSN - 2688-1527
DOI - 10.1200/op.20.00723
Subject(s) - chemoimmunotherapy , medicine , lung cancer , immunotherapy , finance , oncology , cancer , economics
Immunotherapy or chemoimmunotherapy is now standard treatment for most patients with metastatic non-small-cell lung cancer (mNSCLC), yet patient supportive care needs (SCNs) on immunotherapy are not well defined. This study characterized the SCNs and financial hardship of patients with mNSCLC treated with immunotherapy or chemoimmunotherapy and examined the relationship between patient and caregiver cancer-related employment reductions and patient financial hardship.